Fig. 5 | Signal Transduction and Targeted Therapy

Fig. 5

From: Biomarker and genomic analyses reveal molecular signatures of non-cardioembolic ischemic stroke

Fig. 5

Prediction models for clinical outcomes across the subpopulations. a Area under the ROC curve (AUC-ROC) analysis was used to predict stroke recurrence at 1 year using top SNPs and biomarkers. UMAP labeled by (b) predicted probability and (c) incidence of stroke recurrence at 1 year. d Density plots depicting the predicted probability of stroke recurrence at 1 year across the subpopulations. e Area under the ROC curve (AUC-ROC) estimates for the prediction of poor functional outcome (mRS > 2) at 3 months using top SNPs and biomarkers. UMAP labeled by the (f) predicted probability of poor functional outcome and (g) incidence of poor functional outcome (mRS > 2) at 3 months. h Density plots depicting the predicted probability of poor functional outcome (mRS > 2) at 3 months across the subpopulations

Back to article page